UBS’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$22M Buy
132,425
+19,683
+17% +$3.26M 0.02% 699
2014
Q2
$17.6M Sell
112,742
-72,673
-39% -$11.4M 0.01% 767
2014
Q1
$28.2M Buy
185,415
+24,175
+15% +$3.68M 0.03% 520
2013
Q4
$21.4M Sell
161,240
-101,742
-39% -$13.5M 0.02% 582
2013
Q3
$30.5M Buy
262,982
+69,041
+36% +$8.02M 0.03% 430
2013
Q2
$17.9M Buy
+193,941
New +$17.9M 0.02% 559